Benefits of CBD

CBD and THC: What's the Difference?

THC and CBD are both derived from the cannabis plant, but the way they interact with your endocannabinoid system is very different. Both interact with our CB1 receptors which maintain balance in our brains and nervous systems. THC fits neatly into our CB1 receptor and creates an intoxicating, psychoactive effect. CBD fits loosely in this receptor and can actually decrease the negative side effects of THC. Check out this video from Leafly for a basic explanation with visual aide.

Medical research from the National Institutes of Health has cited Cannabidiol (CBD) as a potential treatment for:

-Anxiety Disorders¹

-Alzheimer's²

-Epilepsy³

-Addiction⁴

-Pancreatic Inflammation Associated with Type 1 Diabetes⁵

-Cancer⁶

With the passage of the 2018 US Farm Bill, more research can continue on the uses of CBD as well as the other compounds found in Cannabis sativa plants classified as hemp. As with Marijuana, the "entourage effect" is said to be just as important with hemp products...

Full spectrum hemp products don't contain just CBD, but a variety of other compounds like CBG, CBN, CBDV, CBC etc... These compounds along with terpenes, acids, salts and isomers are all said to contribute to the healing effects of the plant.

Treasure Valley CBD offers raw hemp products and full spectrum CBD products that offer the widest array of natural compounds found in the plant. Our products are well trimmed and cured, cared for by our family and ready to ship directly to you!

12/22/2018 - Cody Weaver

Enter the Shop

¹Blessing, E. M., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015, October). Cannabidiol as a potential treatment for anxiety disorders. Neurotherapeutics, 12(4), 825–836.

²Cheng, D., Spiro, A. S., Jenner, A. M., Garner, B., & Karl, T. (2014). Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice [Abstract]. Journal of Alzheimer's Disease, 42(4), 1,383–1,396.

³Devinsky, O., Cilio, M. R., Cross, H., Fernandez-Ruiz, J., French, J., Hill, C., … & Friedman, D. (2014, June). Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 55(6), 791–802.

⁴Hurd, Y. L., Yoon, M., Manini, A. F., Hernandez, S., Olmedo, R., Ostman, M., & Jutras-Aswad, D. (2015, October). Early phase in the development of cannabidiol as a treatment for addiction: Opioid relapse takes initial center stage. Neurotherapeutics, 12(4), 807–815.

⁵Lehmann, C., Fisher, N. B., Tugwell, B., Szczesniak, A., Kelley, M., & Zhou, J. (2017, February 2). Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes [Abstract]. IOS Press.

⁶Massi, P., Solinas, M., Cinquina, V., & Parolaro, D. (2013, February). Cannabidiol as potential anticancer drug. British Journal of Clinical Pharmacology, 75(2), 303–312.